رجوع

Watch Compare

Advanced Biomed Inc.

جودة البيانات: 83%

ADVB

Nasdaq Services Health Services

KWD 6.52

▲ KWD 0.08 (1.24%)

القيمة السوقية: 8.90 M

السعر

KWD 6.52

القيمة السوقية

8.90 M

نطاق اليوم

KWD 6.07 — KWD 6.98

نطاق 52 أسبوعًا

KWD 3.61 — KWD 48.80

حجم التداول

71,162

فتح KWD 6.26

متوسط 50 يوم / 200 يوم

KWD 4.75

37.34% above

متوسط 50 يوم / 200 يوم

KWD 8.21

20.56% below

Quick Summary

النقاط الرئيسية

ROE of 70.25% indicates high profitability

Negative free cash flow of -6.11 M

P/E of 2.03 — trading at a low valuation

النمو

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

الجودة

Return on Equity

70.25%

أعلى من متوسط القطاع (-15.95%)

ROICN/A

Net MarginN/A

Op. MarginN/A

الأمان

Debt / Equity

N/A

Current Ratio8.56

Interest CoverageN/A

التقييم

PE (TTM)

2.03

أعلى من متوسط القطاع (-1.17)

P/B Ratio0.94

EV/EBITDAN/A

Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Services (502 نظير)

المقياس	السهم	وسيط القطاع
P/E	2.0	-1.2
P/B	0.9	1.4
ROE %	70.3	-16.0
Net Margin %	—	-19.4
Rev Growth 5Y %	—	4.0
D/E	—	0.4

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	4.39 M
ROE	70.25%	ROA	51.31%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-6.11 M
ROIC	N/A	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	8.56
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	9.48 M	Tangible Book Value	9.48 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	2.03	Forward P/E	N/A
P/B Ratio	0.94	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-68.67%
Market Cap	8.90 M	Enterprise Value	8.90 M
Per Share
EPS (Diluted TTM)	0.20	Revenue / Share	N/A
FCF / Share	-4.48	OCF / Share	-4.45
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	-139.42%
SBC-Adj. FCF	N/A	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025
Revenue	—
Net Income	-3.26 M
EPS (Diluted)	-0.16
Gross Profit	—
Operating Income	—
EBITDA	—
R&D Expenses	909,771.0
SG&A Expenses	—
D&A	343,830.0
Interest Expense	—
Income Tax	—

Balance Sheet

Annual, most recent first

Metric	FY2025
Total Assets	6.51 M
Total Liabilities	3.03 M
Shareholders' Equity	3.48 M
Total Debt	—
Cash & Equivalents	—
Current Assets	6.03 M
Current Liabilities	2.89 M